Estimated Radiation-Absorbed Organ Doses with Tositumomab and 131I-Tositumomab Therapy
| Organ regions of interest | Absorbed Doses | ||
|---|---|---|---|
| Median (mGy/MBq) | Range (mGy/MBq) | ||
| Thyroid | 2.71 | 1.4–6.2 | |
| Kidneys | 1.96 | 1.5–2.5 | |
| Upper large intestinal wall | 1.34 | 0.8–1.7 | |
| Lower large intestinal wall | 1.30 | 0.8–1.6 | |
| Heart wall | 1.25 | 0.5–1.8 | |
| Spleen | 1.14 | 0.7–5.4 | |
| Testes | 0.83 | 0.3–1.3 | |
| Liver | 0.82 | 0.6–1.3 | |
| Lungs | 0.79 | 0.5–1.1 | |
| Red marrow | 0.65 | 0.5–1.1 | |
| Stomach wall | 0.40 | 0.2–0.8 | |